Skip to main content
SpringerLink
Log in

Behandlung der disseminierten intravasalen Gerinnung unter besonderer Berücksichtigung der Substitution von Antithrombin

  • Conference paper
Antithrombin — Diagnostik und Therapie

  • 25 Accesses

Zusammenfassung

Bei einer Reihe von Erkrankungen (Tabelle 6.1) kann es sekundär zu einer Aktivierung des Gerinnungssystems kommen. Die disseminierte intravasale Gerinnung (DIC) ist ein erworbener Krankheitsprozeß, bei dem disseminiert lösliches Fibrin in der Mikrozirkulation gebildet wird [15].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baudo F, Caimi TM, de Cataldo F, Ravizza A, Casella G, Palareti G, Legnani C, Ridolfi L, Biagi R, D’Angelo A, Crippa L, Giudice D, Gallioli E (1995) Antithrombin III (AT III) replacement therapy in patients with sepsis and/or post-surgical complications requiring hemodynamic and/or respiratory support: a controlled, double blind, randomized multicenter study. Thromb Haemost 73:1425 (abstract)

    Google Scholar 

  2. Blauhut B, Kramar H, Vinazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39:81–89

    Article  PubMed  CAS  Google Scholar 

  3. Bone RC (1995) Sepsis and controlled clinical trials: the Odyssey continues. Crit Care Med 23:1313–1315

    Article  PubMed  CAS  Google Scholar 

  4. Duswald KH, Jochum M, Schramm W, Fritz H (1985) Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery 98:892–899

    PubMed  CAS  Google Scholar 

  5. Fourrier F, Chopin C, Goudemand J, Hendrycks S, Caron C, Rime A, Marey A, Lestarel P (1992) Septic shock, multiple organ failure and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C and protein S deficiencies. Chest 101:816–823

    Article  PubMed  CAS  Google Scholar 

  6. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882–888

    Article  PubMed  CAS  Google Scholar 

  7. Gabriel DA (1994) The use of antithrombin III in the treatment of disseminated intravascular coagulation. Semin Hematol 31:60–64

    Google Scholar 

  8. Grundmann R, Hornung M (1988) Verlaufskontrolle septischer Patienten auf der Intensivstation mit Hilfe von „Sepsisscore“, Endotoxin- und AT III-Bestimmung. Langenbecks Arch Chir 373:166–172

    Article  PubMed  CAS  Google Scholar 

  9. Hesselvik JF, Blombäck M, Brodin B, Maller R (1989) Coagulation, fibrinolysis, and kallikrein system in sepsis: relation to outcome. Crit Care Med 17:724–733

    Article  PubMed  CAS  Google Scholar 

  10. Inthorn D (1993) Therapie mit Proteinaseinhibitoren. Antithrombin III. In: Schuster HP (ed) Intensivtherapie bei Sepsis und Multiorganversagen. Springer-Verlag, Berlin Heidelberg, pp 91–107

    Google Scholar 

  11. Jochum M (1995) Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Semin Hematol 32, Suppl 2:19–32

    PubMed  CAS  Google Scholar 

  12. Maurin N (1990) Therapie der disseminierten intravasalen Gerinnung (DIC). Therapiewoche 40:3332–3335s

    Google Scholar 

  13. Maurin N, Frank D (1993) Sepsis and septic shock: hemostasis-fibrinoly-sis equilibrium as a prognostic factor and an indicator during therapy. In: Müller-Berghaus G, Madlener K, Blombäck M, ten Cate JW (eds) DIC — Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation. Excerpta Medica International Congress Series 1044, Elsevier, Amsterdam, pp 165–170

    Google Scholar 

  14. Maurin N, Hägel J, Frank D, Stefanidis I (1992) Sepsis und Hämostase. Intensiv- und Notfallbehandlung 17:73–77

    Google Scholar 

  15. Müller-Berghaus G, Blombäck M, ten Cate JW (1993) Attempts to define disseminated intravascular coagulation. In: Müller–Berghaus G, Madiener K, Blombäck M, ten Cate JW (eds) DIC - Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation. Excerpta Medica International Congress Series 1044, Elsevier, Amsterdam, pp 3–8

    Google Scholar 

  16. Okajima K (1996) New therapeutic implications of antithrombin III replacement in disseminated intravascular coagulation and multiple organ failure. Intensivmed 33:5–11

    Google Scholar 

  17. Petros AJ, Marnali JC, van Saene HKF (1995) Should morbidity replace as an endpoint for clinical trials in intensive care? Lancet 345:369–371

    Article  PubMed  CAS  Google Scholar 

  18. Vinazzer H (1989) Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost 15:347–352

    Article  PubMed  CAS  Google Scholar 

  19. Wachtfogel YT, Pixley RA, Kucich U, Abrams W, Weinbaum G, Schapira M, Colman RW (1986) Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 67:1731–1737

    PubMed  CAS  Google Scholar 

  20. Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, Depoli PA (1986) Antithrombin, prekallikrein, and fibronectin levels in surgical patients. Arch Surg 121:635–640

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. N. Maurin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. II. Medizinische Klinik und Poliklinik, Univerasitätsklinikum Mainz, Langenbeckstraße 1, D-55131, Mainz, Germany

    L. S. Weilemann  & H. Schinzel  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Maurin, N. (1998). Behandlung der disseminierten intravasalen Gerinnung unter besonderer Berücksichtigung der Substitution von Antithrombin. In: Weilemann, L.S., Schinzel, H. (eds) Antithrombin — Diagnostik und Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60305-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60305-1_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63635-9

  • Online ISBN: 978-3-642-60305-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation